Value
9.0/10data confidence 33%| Component | Sub-score |
|---|---|
| Analyst target | 9.0 |
- ▸Attractively valued
NGNE · Why this verdict
Why Neurogene (NGNE) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.5/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
The stated risk/reward is heavily favorable, with upside to the analyst-based price target near 99% against about 7% downside to the stop-loss level, producing an asymmetry ratio near 6.6. Targets | The favorable asymmetry should hold or widen if shares continue closing the gap toward the price target without downside accelerating. | →Stable |
| CounterAnalyst coverage is described as light, which the data says dampens the signal behind the price target and the implied upside it is based on. | ||
Quality screens far below the minimum threshold, with the data flagging cash burn (negative free cash flow), no competitive moat, and a weak Piotroski F-score of 2 out of 9. Quality breakdown | Free cash flow turning positive and the Piotroski F-score climbing off its current low would ease this deep quality concern. | →Stable |
| CounterThe company has still beaten or met earnings estimates in three of its last four quarters, suggesting execution has been better than the raw quality score implies. | ||
The stock is overbought with an RSI of 74 while trading above its 200-day moving average, with rising on-balance volume showing continued accumulation. Momentum breakdown | RSI cooling from overbought levels while the stock holds above its 200-day moving average would support a healthy continuation rather than a sharp reversal. | →Stable |
| CounterAn RSI reading this elevated often precedes a near-term pullback, which could test whether the move above the 200-day moving average holds. | ||
Short interest is elevated at 28%, described in the data as justified, alongside implied volatility near 118%. Risk breakdown | A decline in short interest and implied volatility would indicate the elevated bearish positioning and options risk are easing. | →Stable |
| CounterThe put/call ratio itself sits below 1, at about 0.63, which is not obviously consistent with heavy bearish options hedging despite the high short interest. | ||
Insider activity skews bearish, with a net sale of 9,600 shares across two sell transactions over the past 90 days and no offsetting buys. Insider | A shift toward net insider buying, or no further net selling, would indicate the bearish insider signal is easing. | →Stable |
| CounterThe sales are small in share count with no disclosed dollar value, and the engine's own insider-selling severity is rated none rather than elevated. | ||
The stated risk/reward is heavily favorable, with upside to the analyst-based price target near 99% against about 7% downside to the stop-loss level, producing an asymmetry ratio near 6.6.
→StableTargets
- Expectation
- The favorable asymmetry should hold or widen if shares continue closing the gap toward the price target without downside accelerating.
CounterAnalyst coverage is described as light, which the data says dampens the signal behind the price target and the implied upside it is based on.
Quality screens far below the minimum threshold, with the data flagging cash burn (negative free cash flow), no competitive moat, and a weak Piotroski F-score of 2 out of 9.
→StableQuality breakdown
- Expectation
- Free cash flow turning positive and the Piotroski F-score climbing off its current low would ease this deep quality concern.
CounterThe company has still beaten or met earnings estimates in three of its last four quarters, suggesting execution has been better than the raw quality score implies.
The stock is overbought with an RSI of 74 while trading above its 200-day moving average, with rising on-balance volume showing continued accumulation.
→StableMomentum breakdown
- Expectation
- RSI cooling from overbought levels while the stock holds above its 200-day moving average would support a healthy continuation rather than a sharp reversal.
CounterAn RSI reading this elevated often precedes a near-term pullback, which could test whether the move above the 200-day moving average holds.
Short interest is elevated at 28%, described in the data as justified, alongside implied volatility near 118%.
→StableRisk breakdown
- Expectation
- A decline in short interest and implied volatility would indicate the elevated bearish positioning and options risk are easing.
CounterThe put/call ratio itself sits below 1, at about 0.63, which is not obviously consistent with heavy bearish options hedging despite the high short interest.
Insider activity skews bearish, with a net sale of 9,600 shares across two sell transactions over the past 90 days and no offsetting buys.
→StableInsider
- Expectation
- A shift toward net insider buying, or no further net selling, would indicate the bearish insider signal is easing.
CounterThe sales are small in share count with no disclosed dollar value, and the engine's own insider-selling severity is rated none rather than elevated.
TrendMatrix Research · core thesis
Engine thesis — one sentence
Neurogene offers a heavily favorable stated risk/reward against its analyst target and a stock holding above its 200-day moving average, but quality sits far below the minimum floor amid cash burn, the technical setup is overbought, short interest is elevated, and insiders have leaned bearish.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
1.6/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Gross margin | 0.0 |
| Op margin | 0.0 |
| Net margin | 0.0 |
| Current ratio | 5.0 |
| FCF quality | 0.0 |
| Moat | 4.8 |
| Piotroski F | 4.4 |
- ▸Cash-burning (FCF negative)
- ▸No competitive moat
- ▸Quality concerns
Growth
5.0/10data confidence 50%Momentum
8.3/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.4 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 8.2 |
- ▸Overbought (RSI 72)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
7.7/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 7.7 |
| Price target | 10.0 |
| erm sentiment | 5.0 |
- ▸Light analyst coverage (7.0) — signal dampened
- ▸Analyst upside: 112%
Insider
4.6/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 4.5 |
| insider conviction | 2.0 |
| holder change | 7.4 |
- ▸Modest insider selling — $300,043 (0.046% of mkt cap)
Peer rank
5.2/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 5.0 |
| quality rank | 4.8 |
| growth rank | 5.0 |
Technical
3.4/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 0.7 |
| 52w position | 9.5 |
Risk (lower is worse)
3.4/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 0.7 |
| days to cover | 0.0 |
| volatility | 0.0 |
| put call | 10.0 |
| implied vol | 0.0 |
| max pain risk | 3.0 |
| beta | 3.5 |
| debt equity | 9.8 |
- ▸High short interest justified: 28%
- ▸High IV: 114%
- ▸Above max pain $25
- ▸Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
5.1/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 3.7 |
- ▸Strong earnings: 3B/1M
How the verdict was assembled
Engine trigger
Quality below minimum threshold.
Engine technical detail
verdict_path:
L1:HARD_BLOCKPassed (7)
- MOMENTUM:8.3>=5.5
- ASYMMETRY:5.6>=1.5
- INSIDER:OK
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:35d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (0)
none
Warning (1)
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
5.62
Upside
+84.3%
Downside
15.0%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeInst Constrain — Small cap ($0.6B) below institutional reach
SuitabilitySpeculative — Binary industry: Biotechnology
Investment implication
The L1 gate blocked the positive-verdict path: a hard-floor threshold was breached, so dimensional pillars — including Value at 9.0 could not lift the engine output above the verdict floor.
The strongest dimensions are Value at 9.0, Momentum at 8.3, and Sentiment at 7.7; the weakest are Quality at 1.6, Risk (lower is worse) at 3.4, and Technical at 3.4. The V9 engine cleared all gates with 1 warning, producing an asymmetric reward-to-risk of 5.62 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Favorable Analyst Target Asymmetry
Trip ifThe risk/reward ratio compresses below 1.5x from the current 6.63x.
- P2Deeply Weak Quality Cash Burn
Trip ifThe quality score rises above 4.0 from the current 1.2.
- P3Overbought Uptrend Above 200ma
Trip ifThe stock falls below its 200-day moving average, reversing the current above-trend position.
- P4Elevated Short Interest And Iv
Trip ifShort interest falls below 15% of float from the current 28%.
- P5Bearish Insider Selling
Trip ifNet insider transactions turn positive (net buying exceeds 0 shares) over a 90-day period.